Healthy volunteers test new injection method for drug absorption

NCT ID NCT07446101

First seen Mar 09, 2026 · Last updated May 29, 2026 · Updated 10 times

Summary

This study looks at whether a single injection of mirikizumab works as well as two injections in healthy adults. Researchers will check safety and how the body handles the drug. About 450 healthy participants will take part, and the study lasts around 15 weeks. This is an early-stage trial, so no direct treatment benefit is expected for participants.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Axis Clinicals LLC

    RECRUITING

    Dilworth, Minnesota, 56529, United States

    Contact Phone: •••-•••-••••

    Contact

  • Fortrea Clinical Research Unit

    RECRUITING

    Daytona Beach, Florida, 32117, United States

    Contact Phone: •••-•••-••••

    Contact

  • Fortrea Clinical Research Unit

    RECRUITING

    Dallas, Texas, 75247, United States

    Contact Phone: •••-•••-••••

    Contact

  • Fortrea Clinical Research Unit

    RECRUITING

    Madison, Wisconsin, 53704, United States

    Contact Phone: •••-•••-••••

    Contact

  • Worldwide Clinical Trials, Inc.

    RECRUITING

    San Antonio, Texas, 78217, United States

    Contact Phone: •••-•••-••••

    Contact

Conditions

Explore the condition pages connected to this study.